Vesper Medical is a privately held company shaping the future of treating deep venous disease through the creation of the Vesper DUO Venous Stent System®, a next-generation, modular, and uniquely engineered venous stent portfolio that addresses the multiple anatomical challenges presented by the iliac and femoral veins and provides the ability to customize therapy to a broad range of patient needs.
Location: United States, Pennsylvania, Philadelphia
Employees: 11-50
Total raised: $37M
Founded date: 2016
Investors 2
| Date | Name | Website |
| - | Quaker Par... | quakerpart... |
| - | Gilde Heal... | gildehealt... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 04.06.2019 | - | $37M | Gilde Heal... |
Mentions in press and media 3
| Date | Title | Description |
| 12.01.2025 | Vensana Capital: $425 Million Fund III Closed For Investing In Breakthrough Medical Technologies | Vensana Capital announced the closing of Vensana Capital III with $425 million in committed capital. This fund was oversubscribed at its hard cap with the support of the firm’s existing limited partners alongside select new institutional in... |
| 04.06.2019 | Gilde Healthcare co-leads $37M financing of Vesper Medical to complete development of its Duo Venous Stent System | Utrecht (The Netherlands), Cambridge (United States) - Gilde Healthcare today announces its investment in Vesper Medical, Inc. (Wayne, PA), a developer of medical devices for minimally invasive peripheral vascular procedures. Gilde Healthca... |
| 29.05.2019 | Daily funding roundup - May 29th, 2019 | Kytopen raised $3.6M; Pico closed $4.5M; Roger.ai landed $7.35M; Outschool secured $8.5M Exer: Exer is an artificial intelligence mobile technology platform for the fitness industry. Exer has raised $2.5 million in seed funding from Signia ... |